Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meeting; Modification, 17868 [2020-06690]

Download as PDF 17868 Federal Register / Vol. 85, No. 62 / Tuesday, March 31, 2020 / Notices Dated: March 25, 2020. Julia Marie Harrison, Chief, Permits and Conservation Division, Office of Protected Resources, National Marine Fisheries Service. [FR Doc. 2020–06601 Filed 3–30–20; 8:45 am] BILLING CODE 3510–22–P DEPARTMENT OF DEFENSE Office of the Secretary Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meeting; Modification Under Secretary of Defense for Personnel and Readiness, Department of Defense (DoD). ACTION: Notice of Federal Advisory Committee meeting; modification. AGENCY: On February 26, 2020, the DoD published a notice to announce the April 1, 2020 meeting of the Uniform Formulary Beneficiary Advisory Panel. On March 9, 2020, the DoD published a notice that announced that the meeting time had changed. DoD is publishing this notice to announce that this federal advisory committee meeting has been modified to a remote access format. SUMMARY: Open to the public Wednesday, April 1, 2020 from 12:00 p.m. to 3:00 p.m. DATES: The address of the open meeting will be online. The phone number for the remote access is: CONUS: 888–469–2037; OCONUS: 1– 517–308–9287; PARTICIPANT CODE: 8227323. These numbers and the dial-in instructions will also be posted on the Uniform Formulary Beneficiary Advisory Panel website at: https:// www.health.mil/About-MHS/OASDHA/ Defense-Health-Agency/Operations/ Pharmacy-Division/BeneficiaryAdvisory-Panel. FOR FURTHER INFORMATION CONTACT: Colonel Paul J. Hoerner, USAF, 703– 681–2890 (Voice), None (Facsimile), dha.ncr.j-6.mbx.baprequests@mail.mil (Email). Mailing address is 7700 Arlington Boulevard, Suite 5101, Falls Church, VA 22042–5101. Website: https://www.health.mil/About-MHS/ OASDHA/Defense-Health-Agency/ Operations/Pharmacy-Division/ Beneficiary-Advisory-Panel. The most up-to-date changes to the meeting agenda can be found on the website. SUPPLEMENTARY INFORMATION: Due to circumstances beyond the control of the Department of Defense, the Designated Federal Officer for the Uniform jbell on DSKJLSW7X2PROD with NOTICES ADDRESSES: VerDate Sep<11>2014 19:01 Mar 30, 2020 Jkt 250001 Formulary Beneficiary Advisory Panel was unable to provide public notification required by 41 CFR 102– 3.150(a) concerning the modification of the previously noticed meeting for April 1, 2020. Accordingly, the Advisory Committee Management Officer for the Department of Defense, pursuant to 41 CFR 102–3.150(b), waives the 15calendar day notification requirement. On February 26, 2020 (85 FR 11053– 11054), the Department of Defense published a notice that announced an April 1, 2020 meeting of the Uniform Formulary Beneficiary Advisory Panel. On March 9, 2020 (85 FR 13636), the DoD published a notice that announced that the meeting time had changed. DoD is publishing this notice to announce that this federal advisory committee meeting has been modified to a remote access format. Written Statements: Pursuant to 41 CFR 102–3.10, and section 10(a)(3) of FACA, interested persons or organizations may submit written statements to the Uniform Formulary Beneficiary Advisory Panel about its mission and/or the agenda to be addressed in this public meeting. Written statements should be submitted to the Uniform Formulary Beneficiary Advisory Panel’s DFO. The DFO’s contact information can be found in the FOR FURTHER INFORMATION CONTACT section of this notice. Written comments or statements must be received by the Uniform Formulary Beneficiary Advisory Panel’s DFO at least five (5) business days prior to the meeting so they may be made available to the Uniform Formulary Beneficiary Advisory Panel for its consideration prior to the meeting. The Designated Federal Officer will review all submitted written statements and provide copies to all Uniform Formulary Beneficiary Advisory Panel members. Dated: March 26, 2020. Aaron T. Siegel, Alternate OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. 2020–06690 Filed 3–30–20; 8:45 am] BILLING CODE 5001–06–P PO 00000 Frm 00021 Fmt 4703 Sfmt 4703 DEPARTMENT OF ENERGY Federal Energy Regulatory Commission [Docket No. CP20–49–000] Transcontinental Gas Pipe Line Company, LLC; Notice of Schedule for Environmental Review of a Proposed Amendment of the Northeast Supply Enhancement Project On January 31, 2020, Transcontinental Pipe Line Company, LLC (Transco) filed an application in Docket No. CP20–49–000 requesting to amend the Certificate of Public Convenience and Necessity granted by the Federal Energy Regulatory Commission (Commission or FERC) for the Northeast Supply Enhancement Project on May 3, 2019, in Docket No. CP17–101–000. Transco’s proposed amendment involves utilizing an alternative road for permanent access to Compressor Station 206 in Somerset County, New Jersey, rather than constructing the previously approved access road to the site. On February 5, 2020, the Commission issued its Notice of Application for the proposed amendment. Among other things, that notice alerted agencies issuing federal authorizations of the requirement to complete all necessary reviews and to reach a final decision on a request for a federal authorization within 90 days of the date of issuance of the Commission staff’s environmental document for the project. This instant notice identifies the FERC staff’s planned schedule for the completion of an Environmental Assessment (EA) for the proposed amendment. Schedule for Environmental Review Issuance of EA—May 15, 2020 90-day Federal Authorization Decision Deadline—August 13, 2020 If a schedule change becomes necessary, additional notice will be provided so that the relevant agencies are kept informed of project progress. Project Description Transco proposes to amend the Northeast Supply Enhancement Project to utilize an alternative permanent access road to Compressor Station 206 (referred to as the Higgins Farm Access Road) that would involve the use and extension of an existing road rather than construction of the previously approved access road across property owned by Trap Rock Industries (referred to as the Trap Rock Access Road). Transco states the proposal would enable it to comply with requirements from the New Jersey Department of Environmental Protection E:\FR\FM\31MRN1.SGM 31MRN1

Agencies

[Federal Register Volume 85, Number 62 (Tuesday, March 31, 2020)]
[Notices]
[Page 17868]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-06690]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Uniform Formulary Beneficiary Advisory Panel; Notice of Federal 
Advisory Committee Meeting; Modification

AGENCY: Under Secretary of Defense for Personnel and Readiness, 
Department of Defense (DoD).

ACTION: Notice of Federal Advisory Committee meeting; modification.

-----------------------------------------------------------------------

SUMMARY: On February 26, 2020, the DoD published a notice to announce 
the April 1, 2020 meeting of the Uniform Formulary Beneficiary Advisory 
Panel. On March 9, 2020, the DoD published a notice that announced that 
the meeting time had changed. DoD is publishing this notice to announce 
that this federal advisory committee meeting has been modified to a 
remote access format.

DATES: Open to the public Wednesday, April 1, 2020 from 12:00 p.m. to 
3:00 p.m.

ADDRESSES: The address of the open meeting will be online. The phone 
number for the remote access is: CONUS: 888-469-2037; OCONUS: 1-517-
308-9287; PARTICIPANT CODE: 8227323. These numbers and the dial-in 
instructions will also be posted on the Uniform Formulary Beneficiary 
Advisory Panel website at: https://www.health.mil/About-MHS/OASDHA/Defense-Health-Agency/Operations/Pharmacy-Division/Beneficiary-Advisory-Panel.

FOR FURTHER INFORMATION CONTACT: Colonel Paul J. Hoerner, USAF, 703-
681-2890 (Voice), None (Facsimile), [email protected] (Email). Mailing address is 7700 Arlington 
Boulevard, Suite 5101, Falls Church, VA 22042-5101. Website: https://www.health.mil/About-MHS/OASDHA/Defense-Health-Agency/Operations/Pharmacy-Division/Beneficiary-Advisory-Panel. The most up-to-date 
changes to the meeting agenda can be found on the website.

SUPPLEMENTARY INFORMATION: Due to circumstances beyond the control of 
the Department of Defense, the Designated Federal Officer for the 
Uniform Formulary Beneficiary Advisory Panel was unable to provide 
public notification required by 41 CFR 102-3.150(a) concerning the 
modification of the previously noticed meeting for April 1, 2020. 
Accordingly, the Advisory Committee Management Officer for the 
Department of Defense, pursuant to 41 CFR 102-3.150(b), waives the 15-
calendar day notification requirement.
    On February 26, 2020 (85 FR 11053-11054), the Department of Defense 
published a notice that announced an April 1, 2020 meeting of the 
Uniform Formulary Beneficiary Advisory Panel. On March 9, 2020 (85 FR 
13636), the DoD published a notice that announced that the meeting time 
had changed. DoD is publishing this notice to announce that this 
federal advisory committee meeting has been modified to a remote access 
format.
    Written Statements: Pursuant to 41 CFR 102-3.10, and section 
10(a)(3) of FACA, interested persons or organizations may submit 
written statements to the Uniform Formulary Beneficiary Advisory Panel 
about its mission and/or the agenda to be addressed in this public 
meeting. Written statements should be submitted to the Uniform 
Formulary Beneficiary Advisory Panel's DFO. The DFO's contact 
information can be found in the FOR FURTHER INFORMATION CONTACT section 
of this notice. Written comments or statements must be received by the 
Uniform Formulary Beneficiary Advisory Panel's DFO at least five (5) 
business days prior to the meeting so they may be made available to the 
Uniform Formulary Beneficiary Advisory Panel for its consideration 
prior to the meeting. The Designated Federal Officer will review all 
submitted written statements and provide copies to all Uniform 
Formulary Beneficiary Advisory Panel members.

    Dated: March 26, 2020.
Aaron T. Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2020-06690 Filed 3-30-20; 8:45 am]
BILLING CODE 5001-06-P